123 related articles for article (PubMed ID: 30379998)
1. dbCPM: a manually curated database for exploring the cancer passenger mutations.
Yue Z; Zhao L; Xia J
Brief Bioinform; 2020 Jan; 21(1):309-317. PubMed ID: 30379998
[TBL] [Abstract][Full Text] [Related]
2. dbCID: a manually curated resource for exploring the driver indels in human cancer.
Yue Z; Zhao L; Cheng N; Yan H; Xia J
Brief Bioinform; 2019 Sep; 20(5):1925-1933. PubMed ID: 30016397
[TBL] [Abstract][Full Text] [Related]
3. Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.
Bányai L; Trexler M; Kerekes K; Csuka O; Patthy L
Elife; 2021 Jan; 10():. PubMed ID: 33427197
[TBL] [Abstract][Full Text] [Related]
4. Exploring preferred amino acid mutations in cancer genes: Applications to identify potential drug targets.
Anoosha P; Sakthivel R; Michael Gromiha M
Biochim Biophys Acta; 2016 Feb; 1862(2):155-65. PubMed ID: 26581171
[TBL] [Abstract][Full Text] [Related]
5. Sequence Neighborhoods Enable Reliable Prediction of Pathogenic Mutations in Cancer Genomes.
Banerjee S; Raman K; Ravindran B
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34068918
[TBL] [Abstract][Full Text] [Related]
6. PredCID: prediction of driver frameshift indels in human cancer.
Yue Z; Chu X; Xia J
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32591774
[TBL] [Abstract][Full Text] [Related]
7. dbDSM: a manually curated database for deleterious synonymous mutations.
Wen P; Xiao P; Xia J
Bioinformatics; 2016 Jun; 32(12):1914-6. PubMed ID: 27153700
[TBL] [Abstract][Full Text] [Related]
8. PredDSMC: A predictor for driver synonymous mutations in human cancers.
Wang L; Sun J; Ma S; Xia J; Li X
Front Genet; 2023; 14():1164593. PubMed ID: 37051593
[No Abstract] [Full Text] [Related]
9. CanDrA: cancer-specific driver missense mutation annotation with optimized features.
Mao Y; Chen H; Liang H; Meric-Bernstam F; Mills GB; Chen K
PLoS One; 2013; 8(10):e77945. PubMed ID: 24205039
[TBL] [Abstract][Full Text] [Related]
10. Comparison and integration of computational methods for deleterious synonymous mutation prediction.
Cheng N; Li M; Zhao L; Zhang B; Yang Y; Zheng CH; Xia J
Brief Bioinform; 2020 May; 21(3):970-981. PubMed ID: 31157880
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive assessment of computational algorithms in predicting cancer driver mutations.
Chen H; Li J; Wang Y; Ng PK; Tsang YH; Shaw KR; Mills GB; Liang H
Genome Biol; 2020 Feb; 21(1):43. PubMed ID: 32079540
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing between driver and passenger mutations in individual cancer genomes by network enrichment analysis.
Merid SK; Goranskaya D; Alexeyenko A
BMC Bioinformatics; 2014 Sep; 15(1):308. PubMed ID: 25236784
[TBL] [Abstract][Full Text] [Related]
13. A latent variable model for evaluating mutual exclusivity and co-occurrence between driver mutations in cancer.
Shuaibi A; Chitra U; Raphael BJ
bioRxiv; 2024 Apr; ():. PubMed ID: 38712136
[TBL] [Abstract][Full Text] [Related]
14. dbMCS: A Database for Exploring the Mutation Markers of Anti-Cancer Drug Sensitivity.
Shen Y; Zhang Y; Xue W; Yue Z
IEEE J Biomed Health Inform; 2021 Nov; 25(11):4229-4237. PubMed ID: 34314366
[TBL] [Abstract][Full Text] [Related]
15. Assessment of computational methods for predicting the effects of missense mutations in human cancers.
Gnad F; Baucom A; Mukhyala K; Manning G; Zhang Z
BMC Genomics; 2013; 14 Suppl 3(Suppl 3):S7. PubMed ID: 23819521
[TBL] [Abstract][Full Text] [Related]
16. Cancer Driver Log (CanDL): Catalog of Potentially Actionable Cancer Mutations.
Damodaran S; Miya J; Kautto E; Zhu E; Samorodnitsky E; Datta J; Reeser JW; Roychowdhury S
J Mol Diagn; 2015 Sep; 17(5):554-9. PubMed ID: 26320871
[TBL] [Abstract][Full Text] [Related]
17. Discrimination of driver and passenger mutations in epidermal growth factor receptor in cancer.
Anoosha P; Huang LT; Sakthivel R; Karunagaran D; Gromiha MM
Mutat Res; 2015 Oct; 780():24-34. PubMed ID: 26264175
[TBL] [Abstract][Full Text] [Related]
18. A novel missense-mutation-related feature extraction scheme for 'driver' mutation identification.
Tan H; Bao J; Zhou X
Bioinformatics; 2012 Nov; 28(22):2948-55. PubMed ID: 23044540
[TBL] [Abstract][Full Text] [Related]
19. Mut2Vec: distributed representation of cancerous mutations.
Kim S; Lee H; Kim K; Kang J
BMC Med Genomics; 2018 Apr; 11(Suppl 2):33. PubMed ID: 29697361
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous identification of multiple driver pathways in cancer.
Leiserson MD; Blokh D; Sharan R; Raphael BJ
PLoS Comput Biol; 2013; 9(5):e1003054. PubMed ID: 23717195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
